Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Soleno Therapeutics, Inc. (SLNO) had Non-Operating Income/Expense of $1.82M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$32.66M |
|
$-4.71M |
|
$0.70M |
|
$31.96M |
|
$39.18M |
|
$-6.53M |
|
|
Non-Operating Income/Expense |
$1.82M |
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-6.53M |
|
$-6.01M |
|
50.48M |
|
50.48M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$316.79M |
|
$0.17M |
|
$15.52M |
|
$332.31M |
|
$20.94M |
|
$49.84M |
|
$71.22M |
|
$92.17M |
|
$240.14M |
|
$234.31M |
|
$240.14M |
|
50.44M |
|
| Cash Flow Statement Financials | |
$-45.36M |
|
$15.02M |
|
$18.91M |
|
$87.93M |
|
$76.50M |
|
$-11.43M |
|
$24.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.13 |
|
-- |
|
-- |
|
0.17 |
|
0.21 |
|
97.87% |
|
-19.98% |
|
-19.98% |
|
-- |
|
-14.42% |
|
-14.42% |
|
$-45.37M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.30 |
|
1.33 |
|
67.86 |
|
-1.96% |
|
-2.01% |
|
-1.42% |
|
-1.62% |
|
$4.76 |
|
$-0.90 |
|
$-0.90 |
|